Skip to main content

5 Result(s)

within Lindsay Lally Remove this filter

and

  1. No Access

    Article

    Advances in the treatment of polymyalgia rheumatica and giant cell arteritis

    Research published in 2023 has demonstrated the efficacy of sarilumab for IL-6 blockade in polymyalgia rheumatica and of secukinumab for IL-17 blockade in giant cell arteritis (GCA). Furthermore, preliminary r...

    Lindsay Lally, Robert Spiera in Nature Reviews Rheumatology (2024)

  2. Article

    Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City

    Medha Barbhaiya, Marianna B. Frey, Jonah Levine, Gregory Vitone… in Clinical Rheumatology (2022)

    Download PDF (642 KB) View Article

  3. No Access

    Article

    Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on Treatment

    Granulomatosis with polyangiitis is a primary systemic vasculitis commonly described with the typical triad of upper airway, lung, and kidney involvement. Upper and lower airway involvement is characteristic i...

    Sebastian E. Sattui, Lindsay Lally in Current Allergy and Asthma Reports (2020)

  4. No Access

    Chapter

    Antiphospholipid Syndrome: What Should Patients Know?

    Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the production of antiphospholipid antibodies (aPL) resulting in clinical complications such as blood clots and pregnancy complication...

    Doruk Erkan, Ozan Unlu, Lindsay Lally, Michael D. Lockshin in Antiphospholipid Syndrome (2017)

  5. No Access

    Article

    Biomarkers in ANCA-Associated Vasculitis

    Despite recent advances in the treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV), relapse remains common and patients often experience a variable clinical course after ini...

    Lindsay Lally, Robert F. Spiera in Current Rheumatology Reports (2013)